Inovio Pharmaceuticals Stock Forecast - Daily Balance Of Power

INO Stock  USD 4.03  0.11  2.66%   
Inovio Stock Forecast is based on your current time horizon. Although Inovio Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Inovio Pharmaceuticals' systematic risk associated with finding meaningful patterns of Inovio Pharmaceuticals fundamentals over time.
  
As of the 11th of December 2024, Inventory Turnover is likely to drop to 1.70. In addition to that, Payables Turnover is likely to drop to 0.72. As of the 11th of December 2024, Common Stock Shares Outstanding is likely to grow to about 28 M, though Net Loss is likely to grow to (239.2 M).

Open Interest Against 2024-12-13 Inovio Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Inovio Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Inovio Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Inovio Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Inovio Pharmaceuticals' open interest, investors have to compare it to Inovio Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Inovio Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Inovio. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
On April 15, 2024 Inovio Pharmaceuticals had Daily Balance Of Power of (0.03). Balance of Power indicator (or BOP) measures the strength of Inovio Pharmaceuticals market sensitivity to bulls and bears. It estimates the ability of Inovio Pharmaceuticals buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Inovio Pharmaceuticals Balance of Power indicator one can determine a trend of the price direction.
Check Inovio Pharmaceuticals VolatilityBacktest Inovio PharmaceuticalsTrend Details  

Inovio Pharmaceuticals Trading Date Momentum

On April 16 2024 Inovio Pharmaceuticals was traded for  9.64  at the closing time. Highest Inovio Pharmaceuticals's price during the trading hours was 10.21  and the lowest price during the day was  8.35 . The net volume was 747.7 K. The overall trading history on the 16th of April 2024 contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 12.28% . The trading delta at closing time to current price is 11.74% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Inovio Pharmaceuticals to competition

Other Forecasting Options for Inovio Pharmaceuticals

For every potential investor in Inovio, whether a beginner or expert, Inovio Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inovio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inovio. Basic forecasting techniques help filter out the noise by identifying Inovio Pharmaceuticals' price trends.

Inovio Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inovio Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Inovio Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Inovio Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Inovio Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Inovio Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Inovio Pharmaceuticals' current price.

Inovio Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Inovio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inovio Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Inovio Pharmaceuticals stock market strength indicators, traders can identify Inovio Pharmaceuticals entry and exit signals to maximize returns.

Inovio Pharmaceuticals Risk Indicators

The analysis of Inovio Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inovio Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inovio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Inovio Pharmaceuticals to cross-verify your projections.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.43)
Revenue Per Share
0.025
Quarterly Revenue Growth
(0.55)
Return On Assets
(0.40)
Return On Equity
(0.91)
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.